Update on thoracic aortic endovascular grafting using the medtronic talent device.
This article provides a brief update on the current status of the treatment of thoracic aortic pathology using the Medtronic Talent device. Preoperative evaluation and selection criterion along with study design are described for the recently completed Phase II VALOR Trial (Evaluation of the Medtronic AVE Talent Thoracic Stent Graft System for the Treatment of Thoracic Aneurysms). In addition, the results of several recent series for the treatment of degenerative aneurysm and more complex aortic pathology such as transection, rupture and acute and chronic dissection are reviewed.
Kwolek
Christopher J
CJ
Department of Surgery, Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA. klowek@partners.org
Fairman
Ronald
R
D000497:Alloys; D000784:Aortic Dissection / Q000473:pathology / Q000601:surgery; D000792:Angiography; D017544:Aortic Aneurysm, Abdominal / Q000473:pathology / Q000601:surgery*; D017545:Aortic Aneurysm, Thoracic / Q000473:pathology / Q000601:surgery*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D018579:Patient Selection; D011093:Polyethylene Terephthalates; D011474:Prosthesis Design; D015607:Stents; D016896:Treatment Outcome
D000497:Alloys; D011093:Polyethylene Terephthalates; C013616:nitinol